Skip to content
← Back to this collection

PUBLICATIONS · 22663011

Improved survival with MEK inhibition in BRAF-mutated melanoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2012 Jul 12
First author
Flaherty KT

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2012 Jul 12;367(2):171-2. doi: 10.1056/NEJMe1205654.
    note
    Source null
    related pmid
    22663012
    relationship
    Comment in
  2. citation
    N Engl J Med. 2012 Oct 4;367(14):1364; author reply 1365. doi: 10.1056/NEJMc1209663.
    note
    Source null
    related pmid
    23034028
    relationship
    Comment in
  3. citation
    N Engl J Med. 2012 Oct 4;367(14):1364-5. doi: 10.1056/NEJMc1209663.
    note
    Source null
    related pmid
    23034029
    relationship
    Comment in

Authors and identifiers

  1. name
    Flaherty KT
    type
    Author
  2. name
    Robert C
    type
    Author
  3. name
    Hersey P
    type
    Author
  4. name
    Nathan P
    type
    Author
  5. name
    Garbe C
    type
    Author
  6. name
    Milhem M
    type
    Author
  7. name
    Demidov LV
    type
    Author
  8. name
    Hassel JC
    type
    Author
  9. name
    Rutkowski P
    type
    Author
  10. name
    Mohr P
    type
    Author
  11. name
    Dummer R
    type
    Author
  12. name
    Trefzer U
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Flaherty KT
    type
    Author
  2. name
    Robert C
    type
    Author
  3. name
    Hersey P
    type
    Author
  4. name
    Nathan P
    type
    Author
  5. name
    Garbe C
    type
    Author
  6. name
    Milhem M
    type
    Author
  7. name
    Demidov LV
    type
    Author
  8. name
    Hassel JC
    type
    Author
  9. name
    Rutkowski P
    type
    Author
  10. name
    Mohr P
    type
    Author
  11. name
    Dummer R
    type
    Author
  12. name
    Trefzer U
    type
    Author
bibliography ids
  1. nci-bib-732187787569cb00ab3b83f3
book metadata
content sha256
625b67e193eadb4fa7cebab0050290eed5dbd282f2ef9c9637f173150ea6dcc6
document type
citation
dois
  1. 10.1056/NEJMoa1203421
electronic publication date
display
2012 Jun 4
precision
day
year
2012
evidence scope
bibliographic_metadata_only
id
pubmed:22663011
immutable id
pubmed:22663011@625b67e193eadb4fa7cebab0050290eed5dbd282f2ef9c9637f173150ea6dcc6
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
2
name
The New England journal of medicine
nlm unique id
0255562
pages
107-14
volume
367
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2012 Jul 12;367(2):171-2. doi: 10.1056/NEJMe1205654.
    note
    Source null
    related pmid
    22663012
    relationship
    Comment in
  2. citation
    N Engl J Med. 2012 Oct 4;367(14):1364; author reply 1365. doi: 10.1056/NEJMc1209663.
    note
    Source null
    related pmid
    23034028
    relationship
    Comment in
  3. citation
    N Engl J Med. 2012 Oct 4;367(14):1364-5. doi: 10.1056/NEJMc1209663.
    note
    Source null
    related pmid
    23034029
    relationship
    Comment in
outcomes validated
false
pmid
22663011
provenance
batch id
c95be1d0b8cf19942816
provider
NCBI PubMed ESummary
record sha256
a1b6c54e4ad2b8efc1ad1a98d7f2f357af5d27b21c4433cbcac2ee8197ed6311
response sha256
a96bb680a8f3690267e009557d1b07aab71455ba44aeba18695d98a3eeb5fcf2
retrieved at
2026-09-09T23:46:47.691937+00:00
publication date
display
2012 Jul 12
precision
day
year
2012
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/22663011/
title
Improved survival with MEK inhibition in BRAF-mutated melanoma.

Preserved source evidence · Not medical advice